Dr Bram Sengers
No more applications being accepted
Competition Funded PhD Project (UK Students Only)
About the Project
Placental transfer of drugs and other potentially harmful xenobiotics from mother to fetus is a critical safety issue that currently cannot be fully evaluated due to the biological complexity of the transport mechanisms involved. Systems biology approaches using mathematical modelling can provide solutions to capture this complexity, however current pharmacokinetic models for placental transfer are largely phenomenological and fail to reflect the underlying physiology. Therefore, this project will develop novel mechanistic computational models for the functional characterisation of complex biological transport systems and test these extensively against data from the ex-vivo perfused placenta, Transwell and placenta-on-a-chip setup. Such closely integrated computational-experimental tools and technologies are highly timely and will allow for the first time the systematic quantitative evaluation of new and existing compounds and their transport interactions in the placenta.
The successful candidate will have a strong background in computational/mathematical modelling and a degree in a relevant quantitative discipline, such as for example Applied Mathematics, Biomedical Engineering, or Quantitative Pharmacology
If you wish to discuss any details of the project informally, please contact Bram Sengers, research group, Email: [Email Address Removed], Tel: +44 (0) 2380 59 3300.
Funding Notes
This project is in competition with others for funding; the projects which receive the best applicants will be awarded a full studentship. This 3 year studentship covers home-rate tuition fees and provides an annual tax-free stipend at the standard EPSRC rate, which is £14,777 for 2018/19.
The funding is only available to UK citizens or EU citizens who have been resident in the UK for at least 3 years prior to the start of the studentship and not mainly for the purpose of receiving full-time education. For further guidance on funding, please contact [Email Address Removed]
Continue with Facebook
